Does ARNI therapy enhance response to cardiac resynchronization therapy in patients with HFrEF?
ARNI therapy may enhance the clinical response to cardiac resynchronization therapy in patients with HFrEF, especially among those who initially do not respond.
ARNI therapy shows promise in enhancing CRT response in patients with HFrEF, particularly in non-responders. Further large-scale, prospective studies are needed to clarify optimal patient selection and treatment sequencing.
Pătru et al. (Wed,) studied this question.